Kekoolani S. Visan

Kekoolani S. Visan

Auto-generated profile, based on publicly available information

Kekoolani S. Visan

Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2022 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
KVKekoolani S. Visan
Kekoolani S. Visan
RLRichard Lobb
Richard Lobb
SHSunyoung Ham
Sunyoung Ham
LLLuize G. Lima
Luize G. Lima
CPCarlos Palma
Carlos Palma
Andreas MöllerAndreas Möller
Andreas Möller
Small extracellular vesicles (sEVs) provide major promise for advances in cancer diagnostics, prognostics, and therapeutics, ascribed to their distinctive cargo reflective of pathophysiological status, active involvement in intercellular communication, as well as their ubiquity and stability in bodily fluids. As a result, the field of sEV research has expanded exponentially. Nevertheless, there is a lack of standardisation in methods for sEV isolation from cells grown in serum‐containing media. The majority of researchers use serum‐containing media for sEV harvest and employ ultracentrifugation as the primary isolation method. Ultracentrifugation is inefficient as it is devoid of the capacity to isolate high sEV yields without contamination of non‐sEV materials or disruption of sEV integrity. We comprehensively evaluated a protocol using tangential flow filtration and size exclusion chromatography to isolate sEVs from a variety of human and murine cancer cell lines, including HeLa, MDA‐MB‐231, EO771 and B16F10. We directly compared the performance of traditional ultracentrifugation and tangential flow filtration methods, that had undergone further purification by size exclusion chromatography, in their capacity to separate sEVs, and rigorously characterised sEV properties using multiple quantification devices, protein analyses and both image and nano‐flow cytometry. Ultracentrifugation and tangential flow filtration both enrich consistent sEV populations, with similar size distributions of particles ranging up to 200 nm. However, tangential flow filtration exceeds ultracentrifugation in isolating significantly higher yields of sEVs, making it more suitable for large‐scale research applications. Our results demonstrate that tangential flow filtration is a reliable and robust sEV isolation approach that surpasses ultracentrifugation in yield, reproducibility, time, costs and scalability. These advantages allow for implementation in comprehensive research applications and downstream investigations.

18 January 2023 in Communications Biology
Verified
Journal Article
Open access
PDF file
RLRichard J. Lobb
Richard J. Lobb
KVKekoolani S. Visan
Kekoolani S. Visan
LWLi-Ying Wu
Li-Ying Wu
ENEmma L. Norris
Emma L. Norris
MHMarcus L. Hastie
Marcus L. Hastie
Andreas MöllerAndreas Möller
Andreas Möller
Despite significant therapeutic advances, lung cancer remains the leading cause of cancer-related death worldwide1. Non-small cell lung cancer (NSCLC) patients have a very poor overall five-year survival rate of only 10–20%. Currently, TNM staging is the gold standard for predicting overall survival and selecting optimal initial treatment options for NSCLC patients, including those with curable stages of disease. However, many patients with locoregionally-confined NSCLC relapse and die despite curative-intent interventions, indicating a need for intensified, individualised therapies. Epithelial-to-mesenchymal transition (EMT), the phenotypic depolarisation of epithelial cells to elongated, mesenchymal cells, is associated with metastatic and treatment-refractive cancer. We demonstrate here that EMT-induced protein changes in small extracellular vesicles are detectable in NSCLC patients and have prognostic significance. Overall, this work describes a novel prognostic biomarker signature that identifies potentially-curable NSCLC patients at risk of developing metastatic NSCLC, thereby enabling implementation of personalised treatment decisions.

28 May 2026 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
YSYue Su
Yue Su
KVKekoolani S. Visan
Kekoolani S. Visan
SVSarah Voss
Sarah Voss
MPMarta Prieto‐Vila
Marta Prieto‐Vila
JMJuntaro Matsuzaki
Juntaro Matsuzaki
Andreas MöllerAndreas Möller
Andreas Möller
An important topic of discussion amongst the extracellular vesicle (EV) research field is which genetic materials are considered true constituents of EV cargo. What were once regarded as non‐EV components have now evolved to be potentially essential to EV composition, serving as key mediators in communication. Researchers continue to pursue varying methods for the isolation of EVs with the desired content. However, the desired content depends on the source and the requirements of the intended downstream use of EVs. Different isolation methods can modify EV cargo, impacting functional EV‐induced effects and analysis of EV contents. Ensuring that any result produced is truly representative of EVs and not of co‐isolated materials is imperative. Here, we describe a side‐by‐side comparison of the outcomes of EV isolation from plasma of healthy individuals, using size exclusion chromatography and an ultrafast filtration system. Characterisation of EVs was performed by particle (nanoparticle tracking analysis), protein (Bradford assay) and lipid (sulfo‐phospho‐vanillin assay) quantification, morphology visualisation (transmission electron microscopy), microRNA expression (miRNA sequencing) and assessment of protein absence or presence (traditional and capillary‐based western blot analyses, ELISA and mass spectrometry). To our surprise, the isolation methods employed identified significant differences in the protein abundance and composition of the resulting EVs. SEC isolated plasma EVs with high abundance of EV transmembrane and cytosolic markers, as well as corona‐related complement, fibrinogen and extracellular matrix proteins. However, this was accompanied by high quantities of non‐EV immunoglobulins. In contrast, UFF isolated plasma EVs with high abundance of EV integrins and corona‐related complement proteins, albeit with high lipoprotein abundance. Each isolation approach produces EVs with different biomolecular properties, which might provide specific advantages and disadvantages, depending on the intended use of EVs. Therefore, isolation methods need to be tested intensively and selected carefully for downstream applications.

28 April 2022
Verified
Thesis
Closed access
KVKekoolani S. Visan
Kekoolani S. Visan
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.

20 July 2026 in Cancers
Verified
Journal Article
Open access
PDF file
YSYue Su
Yue Su
KVKekoolani S. Visan
Kekoolani S. Visan
SHSunyoung Ham
Sunyoung Ham
XLXuanxuan Li
Xuanxuan Li
SPSu-Ho Park
Su-Ho Park
Andreas MöllerAndreas Möller
Andreas Möller
Background: Head and neck squamous cell carcinoma (HNSCC) remains a major global health challenge due to the lack of effective and non-invasive diagnostic tools, often resulting in late-stage detection of cancer. Small extracellular vesicles (sEVs) have emerged as promising biomarkers for early cancer detection and disease monitoring due to their omnipresence and stability in bodily fluids, such as blood plasma. In addition, cancer-derived sEVs specifically carry cargo reflective of oncogene-derived molecular alterations. In summary, these characteristics position sEVs as a potential platform for non-invasive testing of HNSCC. Methods: Plasma-derived sEVs from HNSCC patients (n = 71) and benign subjects (n = 25) were isolated using size exclusion chromatography. Proteomic profiling via liquid chromatography-tandem mass spectrometry identified potential candidate biomarkers, followed by ELISA validation. Results: Proteomic analyses revealed a significant enrichment of multiple proteins in HNSCC-derived sEVs compared to sEVs derived from non-cancer individuals. The von Willebrand factor (vWF) was significantly higher in HNSCC patient-derived sEVs compared to those derived from benign individuals. A validation cohort confirmed that sEV-associated vWF (sEV-vWF) effectively distinguished HNSCC patients from benign subjects, demonstrating strong diagnostic performance, specifically in laryngeal HNSCC (AUC = 0.82) and oropharyngeal HNSCC (AUC = 0.96) patient cohorts. Moreover, postoperative reductions and recurrence-associated increases in sEV-vWF levels corresponded with clinical outcomes, indicating its potential as a dynamic disease indicator. Conclusions: These findings highlight sEV-vWF as a novel and non-invasive biomarker with potential applications in early detection and real-time monitoring of HNSCC, supporting advancement toward precision liquid biopsy strategies in head and neck oncology.